You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
景峯醫藥(000908.SZ):公司實控人將由葉湘武變更為徐歡霞
格隆匯 10-12 20:49

格隆匯10月12日丨景峯醫藥(000908.SZ)公佈,公司控股股東葉湘武於20211012日簽署了《關於湖南景峯醫藥股份有限公司股份轉讓協議書,擬將其及其一致行動人持有的公司對應43,988,718(合計佔公司總股本的5.00%)協議轉讓給北京洲裕能源科技有限責任公司(洲裕能源), 其中葉湘武轉讓9,244,465股股份,葉高靜轉讓 33,918,998股股份葉湘倫轉讓825,255股股份;股份轉讓價格為5/

同時葉湘武洲裕能源簽署了《投票權委託協》, 葉湘武同意將其所剩餘持有景峯醫藥120,847,486股股份(佔公司總股本的13.74%)的表決權不可撤銷地委託給洲裕能源

次股份轉讓及表決權委託前,葉湘武及其一致行動人共計持有166,963,928,佔公司總股本的18.98%為公司控股股東;洲裕能源未持有公司股份

此次股權協議轉讓及投票權委託完成後洲裕能源將直接持有上市公43,988,718股股份,並通過投票權委託的方式持有上市公司120,847,486股股份所對應的表決權。洲裕能源在上市公司中擁有表決權的股份數量合計為164,836,204 股,占上市公司總股本的18.74%洲裕能源將成為可支配上市公司最大單一表決權的股東。根據協議約定,屆時洲裕能源將成為景峯醫藥的控股股東,公司實際控制人由葉湘武變更為徐歡霞

若葉湘武及其一致行動人將合計持有的公司43,988,718 股股份轉讓洲裕能源和表決權委託能夠得以實施,上市公司控股股東、實際控制人將發生變更。公司將根據進展對股份變動後續事宜及時履行信息披露義務。前述事項存在重大不確定性,敬請廣大投資者注意投資風險,謹慎投資。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account